Specialty
Cataract & Refractive Dermatology & Aesthetics Glaucoma Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Webinar In-person View All Courses
Search
Login

Understanding Long-Term Response Rates and Treatment Dilemmas in Diabetic Macular Edema

By: Antonio Capone Jr, MD, moderator; David M. Brown, MD; Jorge A. Fortun, MD; Adam T. Gerstenblith, MD

Supplement Credits: 1

This continuing medical education (CME) activity captures content from a live symposium held on August 11, 2016, in San Francisco, California.

Expiration Date: Wednesday, January 31, 2018
Release Date: January 2017

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Recognize the importance of early diagnosis and treatment of diabetic macular edema
  • Assess the response of anti-VEGF intravitreal injections for diabetic macular edema
  • Discuss the current and potential future therapies to treat patients with diabetic macular edema who do not respond in a timely fashion to initial treatments
  • Formulate strategies to best treat diabetic macular edema using a multimodal approach

Accreditation and Designation Statement

ACCREDITATION STATEMENT
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosures

Antonio Capone Jr, MD
Associated Retinal Consultants
Royal Oak, Michigan

David M. Brown, MD
Retina Consultants of Houston
Houston, Texas

Jorge A. Fortun, MD
Bascom Palmer Eye Institute
Miami, Florida

Adam T. Gerstenblith, MD
Mid Atlantic Retina Specialists
Hagerstown, Maryland

DISCLOSURE POLICY STATEMENT
It is the policy of Evolve Medical Education LLC that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve Medical Education LLC has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty members have the following financial relationships with commercial interests:

Antonio Capone Jr, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan. Grant/Research Support: Allergan.

David M. Brown, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan; Bayer Corporation; Genentech; Novartis; Regeneron Pharmaceuticals; and Roche. Grant/Research Support: Allergan; Bayer Corporation; Genentech; Novartis; Regeneron Pharmaceuticals; and Roche.

Jorge A. Fortun, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon; and ThromboGenics NV.

Adam T. Gerstenblith, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan; and Regeneron Pharmaceuticals.

EDITORIAL SUPPORT DISCLOSURES
Cheryl Cavanaugh, MS, director of operations, Evolve Medical Education LLC; and Michelle Dalton, medical writer; have no financial relationships with commercial interests. Rishi Singh, MD, peer reviewer, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon; Genentech; Regeneron Pharmaceuticals; and ThromboGenics NV. Grant/Research Support: Alcon; Genentech; and Regeneron Pharmaceuticals.

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC, New Retina MD, Retina Today, or Allergan.

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Pretest

Understanding Long-Term Response Rates and Treatment Dilemmas in Diabetic Macular Edema

Antonio Capone Jr, MD, moderator; David M. Brown, MD; Jorge A. Fortun, MD; Adam T. Gerstenblith, MD

Unit Test

Instructions

Back